Erratum to: 'Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.

Authors	Denise A Yardley, Adam Brufsky, Robert E Coleman, Pierfranco F Conte, Javier Cortes, Stefan Glück, Jean-Mark A Nabholtz, Joyce O'Shaughnessy, Robert M Beck, Amy Ko, Markus F Renschler, Debora Barton, Nadia Harbeck
Journal	Trials (Trials) Vol. 17 Pg. 63 (Feb 03 2016) ISSN: 1745-6215 [Electronic] England
PMID	26841937 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!